China’s State FDA Loses Independence in Merger With Ministry Of Health
This article was originally published in PharmAsia News
Executive Summary
BEIJING - In a major revamping of China's drug regulatory system, China's State FDA will lose part of its rule-making authority during an ongoing merger with the Ministry of Health